Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results
- PMID: 12210449
- DOI: 10.1002/mpo.10121
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results
Abstract
Background: It has been suggested that cerebellar medulloblastoma (M) and primitive neuroectodermal tumors (PNET) arising elsewhere in the nervous system, represent a single entity (M/PNET), although this concept is controversial. Cancer registries permit population-based description of cases reported as medulloblastoma, those reported as PNET and description of the aggregate, M/PNET.
Procedure: We reviewed the 768 cases of M/PNET (633 diagnosed medulloblastoma and 135 diagnosed PNET) among persons under 20 years of age in the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database.
Results: The incidence of M/PNET rose 23%, from 4 per 10(6) person-years in 1973-77 to 4.9 per 10(6) person-years in 1993-98. Cases reported as PNET were more likely than those reported as medulloblastoma to be supratentorial (30.4% vs. 1.9%, P < 0.001) and to be female (42.2% vs. 35.4%, P = 0.13). The difference in 5-year survival between the 600 children with infratentorial medulloblastoma vs. the 49 children with infratentorial PNET was not statistically significant (55% vs. 43%). Regardless of reporting diagnosis, survival was poorer among children age 0-3 years and those with supratentorial tumors. Children diagnosed in the more recent period from 1985-1998 had a longer median survival than children diagnosed in 1973-84 (4.9 years vs. 10 years, P < 0.05). Rates were 42% higher among Whites compared to Blacks (4.5/10(6) person-years vs. 3.1/10(6) person-years, P < 0.01).
Conclusions: We found M/PNET is increasing in incidence and more frequent among Whites. Given that medulloblastoma and PNET are histologically identical and have similar epidemiologic profiles, future studies should provide analyses that combine these entities.
Published 2002 Wiley-Liss, Inc.
Similar articles
-
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children.J Clin Neurosci. 2012 Nov;19(11):1541-4. doi: 10.1016/j.jocn.2012.04.009. Epub 2012 Sep 13. J Clin Neurosci. 2012. PMID: 22981874
-
Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data.Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):341-7. doi: 10.1016/j.ijrobp.2010.08.020. Epub 2010 Oct 29. Int J Radiat Oncol Biol Phys. 2012. PMID: 21035954
-
Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.Acad Radiol. 2012 Jan;19(1):35-9. doi: 10.1016/j.acra.2011.08.018. Epub 2011 Nov 3. Acad Radiol. 2012. PMID: 22054800
-
[Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].Strahlenther Onkol. 2001 Sep;177(9):447-61. doi: 10.1007/pl00002426. Strahlenther Onkol. 2001. PMID: 11591018 Review. German.
-
Primary intracranial neoplasms of infancy and early childhood.Childs Nerv Syst. 1997 Oct;13(10):507-13. doi: 10.1007/s003810050127. Childs Nerv Syst. 1997. PMID: 9403197 Review.
Cited by
-
Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches.Diagnostics (Basel). 2023 Dec 16;13(24):3680. doi: 10.3390/diagnostics13243680. Diagnostics (Basel). 2023. PMID: 38132264 Free PMC article. Review.
-
Pediatric Medulloblastoma: Prognostic Value of Preoperative Blood Cell Ratios.Int J Hematol Oncol Stem Cell Res. 2022 Jul 1;16(3):131-139. doi: 10.18502/ijhoscr.v16i3.10135. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 36694701 Free PMC article.
-
The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes.J Pers Med. 2022 Jun 27;12(7):1050. doi: 10.3390/jpm12071050. J Pers Med. 2022. PMID: 35887547 Free PMC article. Review.
-
New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.Cancers (Basel). 2022 May 3;14(9):2285. doi: 10.3390/cancers14092285. Cancers (Basel). 2022. PMID: 35565414 Free PMC article. Review.
-
Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies.Methods Mol Biol. 2022;2423:215-235. doi: 10.1007/978-1-0716-1952-0_19. Methods Mol Biol. 2022. PMID: 34978701
MeSH terms
LinkOut - more resources
Full Text Sources
Medical